137 related articles for article (PubMed ID: 34565641)
1. [Multiple synchronous lung adenocarcinoma: Interest of molecular biology for staging].
Boukhiar S; Tiffet O; Bayle-Bleuez S; Picot T; Yvorel V; Forest F
Rev Mal Respir; 2021 Nov; 38(9):942-945. PubMed ID: 34565641
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiling aids in understanding the lesion origins of a patient with six synchronous invasive lung adenocarcinomas: a case study.
Song Y; Jia Z; Wu P; Wang W; Ou Q; Bao H; Yu M; Wu X; Liu P; Liang N; Zhang S; Li S
BMC Pulm Med; 2020 Apr; 20(1):80. PubMed ID: 32245453
[TBL] [Abstract][Full Text] [Related]
3. Histopathological and molecular study for synchronous lung adenocarcinoma staging.
Donfrancesco E; Yvorel V; Casteillo F; Stachowicz ML; Patoir A; Tiffet O; Péoc'h M; Forest F
Virchows Arch; 2020 Jun; 476(6):835-842. PubMed ID: 31900636
[TBL] [Abstract][Full Text] [Related]
4. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
Rafael OC; Lazzaro R; Hasanovic A
Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
[TBL] [Abstract][Full Text] [Related]
6. Synchronous Pulmonary Adenocarcinomas.
Pagan CA; Shu CA; Crapanzano JP; Lagos GG; Stoopler MB; Rizvi NA; Heymann JJ; Sonett JR; Fernandes H; Saqi A
Am J Clin Pathol; 2020 Jun; 154(1):57-69. PubMed ID: 32146481
[TBL] [Abstract][Full Text] [Related]
7. Histologic lung cancer subtype differentiates synchronous multiple primary lung adenocarcinomas from intrapulmonary metastases.
Cheng H; Lei BF; Peng PJ; Lin YJ; Wang XJ
J Surg Res; 2017 May; 211():215-222. PubMed ID: 28501120
[TBL] [Abstract][Full Text] [Related]
8. Synchronous primary lung adenocarcinomas harboring distinct MET Exon 14 splice site mutations.
Wang SXY; Lei L; Guo HH; Shrager J; Kunder CA; Neal JW
Lung Cancer; 2018 Aug; 122():187-191. PubMed ID: 30032829
[TBL] [Abstract][Full Text] [Related]
9. Unusual synchronous double primary treatment-naïve lung adenocarcinoma harboring T790M and L858R mutations in early-stage lung cancer.
Weng CF; Chen PJ; Tseng AH; Huang SH; Lee HH
World J Surg Oncol; 2019 Aug; 17(1):148. PubMed ID: 31426797
[TBL] [Abstract][Full Text] [Related]
10. [Synchronous pulmonary adenocarcinoma and primary lymphoma of lung mucosa-associated lymphoid tissue].
Pascua J; Robaina G; Di Tullio F; Samudio M; Mendez J; Auvieux R; Decima T; Salvado A
Medicina (B Aires); 2019; 79(3):208-211. PubMed ID: 31284257
[TBL] [Abstract][Full Text] [Related]
11. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
[TBL] [Abstract][Full Text] [Related]
12. Two lung adenocarcinomas in the same lobe: multiple primaries or intrapulmonary metastasis?
Yoshimoto K; Yoshida J; Ishii G; Nishimura M; Hishida T; Nagai K
Ann Thorac Cardiovasc Surg; 2011; 17(6):584-7. PubMed ID: 21881358
[TBL] [Abstract][Full Text] [Related]
13. KRAS Mutation for Staging Resected Non-Small Cell Lung Cancer.
Canepa M; Patel NR; Griffith RC; Ng TT; Azzoli CG
J Thorac Oncol; 2019 Jul; 14(7):e153-e155. PubMed ID: 31235043
[No Abstract] [Full Text] [Related]
14. Clonality assessment of multifocal lung adenocarcinoma by pathology evaluation and molecular analysis.
Sun W; Feng L; Yang X; Li L; Liu Y; Lv N; Lin D
Hum Pathol; 2018 Nov; 81():261-271. PubMed ID: 30420048
[TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing facilitates differentiating between multiple primary lung cancer and intrapulmonary metastasis: a case series.
Liu C; Liu C; Zou X; Shao L; Sun Y; Guo Y
Diagn Pathol; 2021 Mar; 16(1):21. PubMed ID: 33706781
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report.
Takuwa T; Tanaka F; Yoneda K; Torii I; Hashimoto M; Okumura Y; Matsumoto S; Kondo N; Hasegawa S
Lung Cancer; 2010 Jun; 68(3):498-500. PubMed ID: 20307913
[TBL] [Abstract][Full Text] [Related]
17. Metachronous primary lung adenocarcinomas harboring distinct KRAS mutations.
Hu Y; Ren S; Chen C; Liang Q; Yu F; Liu W
Thorac Cancer; 2020 Jul; 11(7):2018-2022. PubMed ID: 32415761
[TBL] [Abstract][Full Text] [Related]
18. A multidisciplinary approach for the differential diagnosis between multiple primary lung adenocarcinomas and intrapulmonary metastases.
Belardinilli F; Pernazza A; Mahdavian Y; Cerbelli B; Bassi M; Gradilone A; Coppa A; Pignataro MG; Anile M; Venuta F; Della Rocca C; Giannini G; d'Amati G
Pathol Res Pract; 2021 Apr; 220():153387. PubMed ID: 33647865
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Sequencing: A Novel Approach to Distinguish Multifocal Primary Lung Adenocarcinomas from Intrapulmonary Metastases.
Patel SB; Kadi W; Walts AE; Marchevsky AM; Pao A; Aguiluz A; Mudalige T; Liu Z; Deng N; Lopategui J
J Mol Diagn; 2017 Nov; 19(6):870-880. PubMed ID: 28866070
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathology and genetic profile of synchronous multiple small adenocarcinomas: implication for surgical treatment of an uncommon lung malignancy.
Lin MW; Wu CT; Kuo SW; Chang YL; Yang PC
Ann Surg Oncol; 2014 Aug; 21(8):2555-62. PubMed ID: 24643899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]